Fermi is trading 4.1% down at $6.32 as investors continue to react to last week’s upsized $375 million convertible senior notes offering and related dilution concerns.
- The stock previously fell approximately 14% on July 10, 2026, after the notes were priced with a 5.00% rate and a 2031 maturity.
- Today’s decline reflects continued market digestion of the financing deal against a backdrop of broader weakness in the biotech and AI sectors.